GoodRx Holdings (GDRX) Long-Term Investments (2020)
GoodRx Holdings recorded quarterly Long-Term Investments of $711.4 million in Q4 2020.
GoodRx Holdings' Long-Term Investments history runs 1 years deep, the most recent figure standing at $711.4 million for Q4 2020.
- In Q4 2020, Long-Term Investments changed N/A year-over-year to $711.4 million; the TTM figure through Dec 2020 stood at $711.4 million (changed N/A YoY), while the FY2020 annual figure was $711.4 million, changed N/A from the prior year.
- Long-Term Investments came in at $711.4 million for Q4 2020 at GoodRx Holdings.
- In the past five years, Long-Term Investments ranged from a high of $711.4 million in Q4 2020 to a low of $711.4 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 714,000.00 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 89.77 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | GoodRx Holdings | 1.05 Bn | 814.83 Mn | 112.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 711.38 Mn |